Department of Radiology, Mayo Clinic, Rochester, Minnesota;
Department of Radiology, Mayo Clinic, Rochester, Minnesota.
J Nucl Med Technol. 2024 Jun 5;52(2):107-114. doi: 10.2967/jnmt.123.266856.
Molecular breast imaging (MBI) is one of several options available to patients seeking supplemental screening due to mammographically dense breasts. Patient experience during MBI may influence willingness to undergo the test but has yet to be formally assessed. We aimed to assess patient comfort level during MBI, to compare MBI comfort with mammography comfort, to identify factors associated with MBI discomfort, and to evaluate patients' willingness to return for future MBI. A 10-question survey was sent by e-mail to patients undergoing MBI between August and December 2022 to obtain quantitative assessments and qualitative opinions about MBI. Of 561 invited patients, 209 (37%) completed the survey and provided study consent. Their average age was 60.1 y (range, 40-81 y). Of the 209 responders, 202 (97%) were presenting for screening MBI, 195 (94%) had dense breasts, and 46 (22%) had a personal history of breast cancer. The average rating of MBI comfort was 2.9 (SD, 1.5; median, 3.0) on a 7-point scale (1 indicating extremely comfortable and 7 indicating extremely uncomfortable). The rating distribution was as follows: 140 (67%) comfortable (rating, 1-3); 24 (12%) neither comfortable nor uncomfortable (rating, 4); and 45 (22%) uncomfortable (rating, 5 or 6). No responders gave a 7 rating. The most frequently mentioned sources of discomfort included breast compression ( = 16), back or neck discomfort ( = 14), and maintaining position during the examination ( = 14). MBI comfort was associated with responder age (74% ≥55 y old were comfortable, versus 53% <55 y old [ = 0.003]) and history of MBI (71% with prior MBI were comfortable, versus 61% having a first MBI [ = 0.006]). Of 208 responders with a prior mammogram, 148 (71%) said MBI is more comfortable than mammography (a significant majority [ < 0.001]). Of 202 responders to the question of whether they were willing to return for a future MBI, 196 (97%) were willing. A notable factor in positive patient experience was interaction with the MBI nuclear medicine technologist. Most responders thought MBI to be a comfortable examination and more comfortable than mammography. Patient experience during MBI may be improved by ensuring back support and soliciting patient feedback at the time of positioning and throughout the examination. Methods under study to reduce imaging time may be most important for improving patient experience.
分子乳腺成像(MBI)是因乳腺致密而寻求补充筛查的患者的几种选择之一。患者在 MBI 期间的体验可能会影响他们接受检查的意愿,但尚未进行正式评估。我们旨在评估 MBI 期间的患者舒适度,比较 MBI 与乳房 X 光检查的舒适度,确定与 MBI 不适相关的因素,并评估患者对未来 MBI 的意愿。 2022 年 8 月至 12 月期间,我们通过电子邮件向接受 MBI 的患者发送了一份 10 个问题的调查,以获得关于 MBI 的定量评估和定性意见。 在邀请的 561 名患者中,有 209 名(37%)完成了调查并同意参与研究。他们的平均年龄为 60.1 岁(范围,40-81 岁)。在 209 名应答者中,有 202 名(97%)正在接受筛查性 MBI,195 名(94%)乳房致密,46 名(22%)有乳腺癌个人史。MBI 舒适度的平均评分为 7 分制的 2.9(标准差,1.5;中位数,3.0)(1 表示非常舒适,7 表示非常不适)。评分分布如下:140 名(67%)舒适(评分 1-3);24 名(12%)既不舒适也不舒适(评分 4);45 名(22%)不适(评分 5 或 6)。没有应答者给 7 分。最常提到的不适来源包括乳房压迫(=16)、背部或颈部不适(=14)和检查期间保持姿势(=14)。MBI 舒适度与应答者年龄(≥55 岁的 74%感到舒适,而 <55 岁的 53%感到舒适[=0.003])和 MBI 史(有既往 MBI 的 71%感到舒适,而首次 MBI 的 61%感到舒适[=0.006])相关。在 208 名有既往乳房 X 光检查的应答者中,有 148 名(71%)表示 MBI 比乳房 X 光检查更舒适(绝大多数[<0.001])。在 202 名是否愿意接受未来 MBI 的问题中,有 196 名(97%)表示愿意。积极的患者体验的一个显著因素是与 MBI 核医学技师的互动。 大多数应答者认为 MBI 是一种舒适的检查,比乳房 X 光检查更舒适。MBI 期间的患者体验可以通过确保背部支撑以及在定位和整个检查过程中征求患者的反馈来改善。正在研究的减少成像时间的方法可能对改善患者体验最为重要。